FDMT
4D Molecular Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:52:41 AM EST
10.70USD+2.294%(+0.24)31,419
FDMT Financials
In Q3 FY 2026 (ended ), 4D Molecular Therapeutics, Inc. Common Stock (FDMT) reported revenue of $4.15M, net income of −$78.06M, operating cash flow of −$56.71M, and assets of $428.75M (filed ).
Loading business breakdowns…